The metabolite of ivabradine CAS: 215935-23-2

Product Parameters
Catalog No. BK9D07
CAS.RN 215935-23-2
Molecular Formula C26H34N2O5
Molecular Weight 454.56 g/mol
Purity NLT 98%
Synonyms N-Demethylivabradine
Product Overview

This product is a metabolite of ivabradine, belonging to the category of pharmaceutical intermediates, primarily used in drug development and synthetic process research. As a key intermediate, it is widely used in the development and optimization of cardiovascular drugs, suitable for different stages including laboratory research, small-scale preparation, pilot-scale amplification, and commercial production. Its high purity and stable chemical properties ensure reliability and consistency in subsequent synthesis, making it an important raw material for pharmaceutical companies in exploring drug process routes and controlling quality.

Applications
  • Drug metabolism research
  • Synthesis of cardiovascular drug intermediates
  • Process route optimization and validation
  • Preclinical research sample preparation
  • Customized pharmaceutical synthesis services
Quality & Supply Capability

English Name: The metabolite of ivabradine Properties: White to off-white crystalline powder with good thermal and chemical stability. Contains specific functional groups, suitable for drug molecule construction and modification. Storage Recommendations: Store in a sealed, light-protected, and dry place, according to the COA/MSDS. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches. Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging. Documentation Support: COA, MSDS, HPLC, NMR, etc. We provide comprehensive supply services from laboratory samples to industrial-scale production, covering small-scale preparation, pilot-scale amplification, and customized batch production. We can flexibly adjust purity standards, impurity control schemes, packaging specifications, and delivery cycles according to customer needs, while providing a complete quality documentation system to ensure product compliance with GMP and R&D requirements. We also provide full-process technical support from laboratory R&D to process scale-up, helping customers achieve efficient transformation from concept to product.

Why Choose Bioncan

Focused on pharmaceutical intermediates, with extensive experience in metabolite synthesis and purification. Full-scale supply capability to meet diverse needs from R&D to commercialization. Comprehensive quality control documentation, including key data such as COA, HPLC, and NMR. Customization support, adjusting purity, impurity control, and packaging specifications according to customer requirements. Support for process optimization and scale-up technologies to improve customer R&D efficiency and commercialization rates.

Intermediates of Ivabradine hydrochloride
Catalog No. Product Name CAS
BA05GW Ivabradine hydrochloride API 148849-67-6
BK82Q4 4,5-Dimethoxy-1-cyanobenzocyclobutane 35202-54-1
BK598V (1S)-4,5-Dimethoxy-1-[(methylamino)methyl]benzocyclobutane hydrochloride 866783-13-3
BK33FJ 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one 73942-87-7
BK56VJ (S)-1-(3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)-N-methylmethanamine 866783-12-2
BK206L Dehydro ivabradine 1086026-31-4
BK4YJ2 N-(3-Bromopropyl)-Phthalimide 5460-29-7
BK3E8G 2,2-Dimethoxy acetaldehyde 51673-84-8
BK40K6 1,1-Diethoxyethene 2678-54-8
BK9D07 The metabolite of ivabradine 215935-23-2
BK752T 3,4-DimethoxyPhenylethylamine 120-20-7
BK364P C-(3,4-DIMETHOXY-BICYCLO[4.2.0]OCTA-1(6),2,4-TRIEN-7-YL)-METHYLAMINE 73344-75-9
BK96F9 (3,4-DiMethyoxy-bicyclo(4,2,0)octa-1(6),2,4-trien-7-ylMethyl)-carbaMic acid ethyl ester 148870-55-7
BK8YQ4 7,8-Dimethoxy-3-(3-iodopropyl)-1,3-dihydro-2H-3-benzazepin-2-one 148870-57-9
BK7CK9 Propanedioic acid, 2-​(2-​bromo-​4,​5-​dimethoxyphenyl)​-​, 1,​3-​dimethyl ester 1069115-30-5
BK1AT9 Bicyclo[4.2.0]​octa-​1,​3,​5-​triene-​7,​7-​dicarboxylic acid, 3,​4-​dimethoxy-​, 7,​7-​dimethyl ester 1069115-32-7
BK9Z16 7,8-Dimethoxy-1,3-dihydro-2H-3-benzazepin-2-one hydrochloride 163629-94-5
BK813C 4,5-diMethoxy-N-Methyl-1,2-dihydrocyclobutabenzene-1-carboxaMide 1206230-27-4
BK2BU0 3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methylamino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 148870-58-0
BK2PD7 3-(3-(((S)-4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one hydrochloride 1393427-01-4
BK5KH5 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methylamino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 1393427-02-5
BK45M1 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(2,2-dimethoxyethyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 1393427-03-6
BK5EL6 (3,4-DiMethoxyphenyl)acetyl chloride 10313-60-7
BK8E10 7,8-Dimethoxy-3-(3-((2-(3,4-dimethoxyphenyl)acetyl)(methyl)amino)propyl)-2,3-dihydro-1H-benzo[d]azepin-2-one 1393427-04-7
BK2YU2 4,5-DIBROMOVERATROLE 37895-73-1
BK67FH (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one 1-oxide 1132079-01-6
BK2Z7N (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2-oxo-2,3-dihydro-1H-benzo[d]azepin-1-ium chloride 1246638-10-7
BK0F52 Bicyclo[4.2.0]​octa-​1,​3,​5-​triene-​7-​carboximidamide, 3,​4-​dimethoxy-​N-​methyl-​N-​[3-​(1,​2,​4,​5-​tetrahydro-​7,​8-​dimethoxy-​2-​oxo-​3H-​3-​benzazepin-​3-​yl)​propyl]​- 1246672-58-1
BK8Q64 7,8-Dimethoxy-3-(3-((2-(3,4-dimethoxyphenyl)ethyl)amino)propyl)-2,3-dihydro-1H-benzo[d]azepin-2-one 98062-25-0
BK85JV 3-chloro-N-{[(7S)-3,4-dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl]methyl}-N-methyl-1-propanamine 1031767-71-1
BK5F84 (S)-N-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)-N-methyl-3-(7,8-dimethoxy-2-oxo-2,3-dihydro-1H-benzo[d]azepin-3-yl)propan-1-aminium chloride 1325209-22-0
BK515P (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one sulfate 1325209-23-1
BK5J56 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one mesylate 1325209-25-3
BK32MX (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one hydrobromide 1325209-24-2
BK1E79 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one phosphate 1325209-26-4
BK36R2 (S)-3-(3-((4,5-Dimethoxybicyclo[4.2.0]octa-1,3,5-trien-7-yl)methyl)(methyl)amino)propyl)-7,8-dimethoxy-2,3-dihydro-1H-benzo[d]azepin-2-one acetate 1325209-27-5
Products are offered for research, development, or industrial use only.
Customers are responsible for ensuring compliance with applicable patent, regulatory, and import/export requirements in their respective jurisdictions.
Online Consulting

For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 215935-23-2, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.